Intracellular Delivery of siRNAs Targeting AKT and ERBB2 Genes Enhances Chemosensitization of Breast Cancer Cells in a Culture and Animal Model

Pharmacotherapy as the mainstay in the management of breast cancer suffers from various drawbacks, including non-targeted biodistribution, narrow therapeutic and safety windows, and also resistance to treatment. Thus, alleviation of the constraints from the pharmacodynamic and pharmacokinetic profil...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatemian, Tahereh, Moghimi, Hamid Reza, Chowdhury, Ezharul Hoque
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781320/
https://www.ncbi.nlm.nih.gov/pubmed/31484456
http://dx.doi.org/10.3390/pharmaceutics11090458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6781320/
https://www.ncbi.nlm.nih.gov/pubmed/31484456
http://dx.doi.org/10.3390/pharmaceutics11090458

Ejemplares similares